Motor neuron cell death in a mouse model of FALS is not mediated by the p53 cell survival regulator

J Prudlo1, J Koenig, J Gräser

  • 1Neurologische Klinik, Universität des Saarlandes, 66421, Homburg/Saar, Germany.

Brain Research
|September 30, 2000
PubMed

Insights

Familial amyotrophic lateral sclerosis (FALS) progression in G93A mutant mice does not depend on the p53 cell survival regulator. Motor neuron loss occurs regardless of p53 status, indicating alternative cell damage pathways in FALS.

Area of Science:

  • Neuroscience
  • Genetics
  • Cell Biology

Background:

  • Mutant Cu/Zn superoxide dismutase (SOD1) is linked to familial amyotrophic lateral sclerosis (FALS).
  • Motor neuron degeneration in FALS involves apoptosis, often regulated by p53.
  • The precise mechanisms of motor neuron damage in FALS remain unclear.

Purpose of the Study:

  • To investigate the role of the p53 cell survival regulator in motor neuron disease (MND) pathogenesis in mice expressing the G93A mutant SOD1.
  • To determine if p53 is essential for the development of MND in this FALS mouse model.

Main Methods:

  • Crossed G93A mutant SOD1 mice with p53-knockout mice to create double transgenic G93A/p53-/- mice.
  • Monitored survival rates and clinical signs of MND in the G93A/p53-/- mice.
  • Performed histological analysis of motor neurons in pre-symptomatic and symptomatic mice, examining for disease-associated vacuoles.

Main Results:

  • Despite shorter lifespans in p53-/- mice, some G93A/p53-/- double transgenics developed MND.
  • The onset and progression of MND in G93A mice were not significantly altered by the absence of p53.
  • Histological examination revealed disease-associated vacuoles in motor neuron dendrites of G93A mice irrespective of their p53 status.

Conclusions:

  • Motor neuron disease in G93A mutant SOD1 mice does not require the p53 cell survival regulator.
  • These findings suggest that p53-independent pathways mediate motor neuron degeneration in this model of FALS.
  • Further research is needed to elucidate the specific cell damage mechanisms driving FALS progression.